Baynes Roy D. bought TVTX

April 14, 2026 · Form 4 insider transaction

Baynes Roy D. bought 4,500 shares of Travere Therapeutics, Inc. at $18.27 per share, a transaction worth $82.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.